Myeloperoxidase (MPO), the most abundant neutrophil protein, is a bacteriocidal component of the primary granules and a critical marker in distinguishing acute myelogenous leukemia from acute lymphoid leukemia. A cDNA clone for human MPO was isolated by immunologic screening of human hematopoietic Xgtll expression vector libraries with specific anti-MPO antibody. The identity of the cDNA clone was confirmed by rinding that (i) epitope-selected antibody against this clone recognizes purified MPO and MPO in human promyelocytic (HL-60) cell lysates by immunoblot analysis, and that (ii) hybrid selection of HL-60 mRNA with this cDNA clone and translation in vitro results in the synthesis of an 80-kDa protein recognized by the anti-MPO antiserum. RNA blot analysis with this MPO cDNA clone detects hybridization to two polyadenylylated transcripts of :3.6 and r2.9 kilobases in HL-60 cells. No hybridization is detected to human placenta mRNA. Upon induction of HL-60 cells to differentiate by incubation for 4 days with dimethyl sulfoxide, a drastic decrease in the hybridization intensity of these two bands is seen. This is consistent with previous data suggesting a decrease in MPO synthesis upon such induction of these cells. The MPO cDNA should be useful for further molecular and genetic characterization of MPO and its expression and biosynthesis in normal and leukemic granulocytic differentiation.
Myeloperoxidase (MPO), a critical microbicidal protein of mature polymorphonuclear neutrophils, is a hemoprotein composing 3-5% of the protein weight of these cells (1, 2) . It appears in the primary azurophilic granules during the differentiation of the neutrophil (3, 4) and has been used as a marker for these granules (5) . Cytochemical staining of MPO activity is used clinically to distinguish acute myeloid leukemia from acute lymphoid leukemia (6) . Furthermore, approximately 1 in every 2000 individuals has been shown to be deficient in MPO (7) , an apparently benign but poorly understood hereditary disorder of polymorphonuclear neutrophils.
Although the function of MPO in the oxygen-dependent respiratory burst of polymorphonuclear neutrophils has been firmly established, relatively little is known about MPO biosynthesis, posttranslational modification, and genetic organization and expression. The exact structure of MPO remains a source of some controversy, and its amino acid sequence is not known.
The appearance of MPO in the primary granules marks the transition from the myeloblast to the promyelocyte in the course of normal neutrophilic differentiation (3) . Promyelocytes, however, are not found in the peripheral blood of normal individuals and are therefore difficult to study biochemically. The HL-60 cell line, derived from a patient with acute promyelocytic leukemia, contains virtually 100%o promyelocytes with azurophilic granules containing MPO (8) .
When HL-60 cells are cultured in the presence of compounds such as dimethyl sulfoxide (Me2SO) (8) or retinoic acid (9) , these cells mature into metamyelocytes, neutrophilic bands, and even mature polymorphonuclear neutrophils having some normal functional characteristics (10) . HL-60 cells are therefore a good model in which to study both normpal and leukemic granulopoiesis in vitro.
Recent studies using metabolic protein labeling of HL-60 cells and immunoprecipitation of in vitro translation products of total cellular HL-60 mRNA (11) (12) (13) suggest that MPO expression peaks during the promyelocyte stage and declines thereafter. Due to lack of cDNA probes, no direct examination to date of MPO mRNA levels at various stages of granulocytic differentiation has been possible. We have undertaken the isolation of cDNA clone(s) for MPO to obtain information about its amino acid sequence and to examine the organization and expression of the MPO gene(s) in both normal and leukemic hematopoietic cells. We report here the isolation of a cDNA clone for human MPO and describe its use to directly examine MPO mRNA during the induction of HL-60 cells.
MATERIALS AND METHODS
MPO Purification and Antibody Production. MPO was purified from a 0.2 M acetate (pH 4.0) extract of granules from leukocytes of a patient with chronic myelogenous leukemia as described (14) . Rabbit antiserum to MPO was prepared by subcutaneous injection of 100 ug of purified MPO in Freund's complete adjuvant, followed by a booster injection (14) . Antiserum was used at a 1:250 dilution.
Cells. The human promyelocytic cell line HL-60 was grown in RPMI 1640 medium supplemented with 1% L-glutamine/ 1% penicillin/1% streptomycin/15% heat-inactivated fetal calf serum at 370C in humidified 5% CG2/95% air. HL-60 cells were differentiated to granulocytes (8) by induction with 1.2% Me2SO. On day 4, the cells were examined for viability and morphology by the ability to exclude trypan blue and Giemsa staining, respectively.
"Normal" human bone marrow was obtained from nonleukemic individuals after informed consent was obtained. Marrow Burnette (17) . Unreacted sites were blocked with 5% nonfat dry milk in phosphate-buffered saline (PBS; 0.8% NaCl/0.02%XKCl/0.02% KH2PO4/0.11% Na2HPG4). Filters were incubated overnight at 40C in primary antibody. Unbound antibody was removed by four consecutive washes of PBS, PBS containing 0.05% Nonidet P-40 twice, and PBS again. To detect specifically bound antibody, the filters were incubated with '25I-labeled goat anti-rabbit IgG or '25I-labeled goat anti-mouse IgG (2-5 x 105 cpm/ml) for 2-4 hr at room temperature, washed as described above, and exposed to x-ray film for autoradiography (12-18 hr) .
Immunologic Screening of Xgtll cDNA Libraries. RNA was isolated from both normal human bone marrow and HL-60 cells by the method of'Chirgwin (18) and polyadenylylated mRNA was selected by chromatography on oligo(dT)-cellulose (19) . Double-stranded cDNA was synthesized from HL-60 and bone marrow poly(A)+ RNA using the S1 nuclease (20) Epitope Selection. Bacteriophages (10,000 plaque-forming units) were used to infect Y1090 at 420C for 4 hr on 85-mm agar plates. IPTG (10 mM) was used to induce expression of fusion proteins. Filters were blocked in 5% nonfat dry milk in PBS, incubated with rabbit antiserum to MPO, and washed as described above. Affinity-purified antibodies immobilized on each filter were eluted with three 2-ml 2-min washes in 5
Proc. Natl. Acad. Sci. USA 84 (1987) mM glycine*HCl, pH 2.3/150 mM NaCl/0.5% Triton X-100/100 Ag of bovine serum albumin per ml according to Weinberger (24) . The Two additional types of experiments were performed to further confirm the identity of clone XHMP7 as a true MPO clone. Epitope selection as described above demonstrated that specific antibodies from the anti-MPO antiserum affinitypurified on and then eluted from filters adsorbed with induced fusion protein ofimmunopositive clone XHMP7, continued to recognize MPO by immunoblot analysis. Both the "parent" antibody as well as the epitope-selected antibody clearly recognized the 55-and 39-kDa subunits in a sample ofpurified MPO (Fig. 2) . Furthermore, the same epitope-selected antibody recognized, in HL-60 lysate, an 80-kDa protein, which is the MPO precursor, as well as bands corresponding to processed MPO (see Discussion). The somewhat lower molecular mass of the MPO bands seen in HL-60 cells is a variable finding and most probably results from proteolysis. Antibody epitope selected against wild-type Xgt11, however, failed to recognize any of these MPO-specific proteins. The fusion protein therefore contains a moiety of MPO that can be used for successful immunoselection of specific anti-MPO antibodies from antiserum.
The cDNA insert of clone XHMP7 was used for the hybrid selection of poly(A)+ mRNA from uninduced HL-60 cells. For this as well as subsequent experiments, the 270-base-pair cDNA insert from the initial clone XHMP7 was subcloned into the twin bacteriophage promoter plasmid pGEM-1. The mRNA hybrid-selected by pHMP7 specifically translated in vitro an 80-kDa protein that was immunoprecipitated with the anti-MPG antibody (Fig. 3) . This is the expected size MPO precursor protein synthesized by HL-60 cells (11, 12, 27) . No bands were seen when pGEM-1 alone was used in a similar experiment. Thus, additional confirmation for the identity of clone XHMP7 as a true MPG clone was provided.
To cells was fractionated by electrophoresis in a denaturing formaldehyde/agarose gel, blotted onto nitrocellulose paper, and hybridized with nick-translated pHMP7. The radioactive cDNA hybridized at high stringency to two major bands from HL-60 cells at =3.6 and -2.9 kilobases (Fig. 4) . A striking decrease in the hybridization intensity of both bands was seen when an equal amount of poly(A)+ RNA from HL-60 cells, induced toward terminal differentiation with Me2SO, was probed. No hybridization was detected to human placenta poly(A)+ RNA. To ensure that lack of hybridization to placenta RNA was due to lack of homology and not degradation of the sample, it was also probed with a nick-translated clone for human nuclear hnRNP C proteins (data not shown). Two bands were detected in placenta poly(A)+ RNA of the expected sizes of 1.9 and 1.4 kilobases (28). These same two bands were also detected with similar intensities in both induced and uninduced HL-60 cellular poly(A)+ RNA. This indicated that the decrease in hybridization intensity of the 3.6-and 2.9-kilobase bands was truly the result of Me2SO induction and not degradation of the sample.
DISCUSSION
Understanding the molecular biology and molecular genetics of MPO is important for several reasons. First, MPO biosynthesis has been intimately linked to myeloid differentiation. Data regarding regulation of MPO biosynthesis should provide insight into the events associated with both normal and leukemic granulopoiesis. Second, analysis of MPO at the protein level has been complicated by ambiguous reports regarding its structure and biosynthesis.
In myeloid cells, MPO activity has been cytochemically localized at both the light and electron microscope levels to the primary granules (3, 4) . MPO is unique to and the most abundant component of myeloid cell primary lysosomes and therefore has been regarded as "the marker" of granulocytic lineage. MPOs first appearance morphologically marks the transition of the primitive myeloblast to the promyelocyte. MPO activity persists in the granules of terminally differentiated neutrophils, yet we (29) and others (30) have shown that these cells are essentially translationally inactive, with little or no detectable poly(A)+ RNA. The mechanism of this shutdown may be best elucidated with probes for specific proteins such as MPO to examine their "window" of genetic expression.
Studies of MPO biosynthesis, gene regulation, and expression require active granulopoiesis. The HL-60 cell line is useful because it produces azurophilic granules with high MPO content (8) . Furthermore, when HL-60 cells are induced to differentiate into more mature granulocytes, MPO activity decreases (13) . This was confirmed by decreased reactivity by immunoblot analysis (S.C.W. and R. Villanueva, unpublished results).
To examine whether the decrease of MPO during differentiation of HL-60 cells was due to degradation or reduced biosynthesis, several groups have conducted studies involving pulse-labeling and immunoprecipitation of translation products of total cellular HL-60 mRNA during various stages of chemical induction (11) (12) (13) 27 (11) (12) (13) 27) suggest that the primary translational protein is a direct precursor of molecular mass =80 kDa, which appears to be processed into a heavy chain (55 kDa) and a light chain (15 kDa 
